Zobrazeno 1 - 10
of 28
pro vyhledávání: '"J. Lacy Sturdivant"'
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::588b10aca98a3ef07ed41e4403ab4994
https://doi.org/10.1161/circep.120.008631
https://doi.org/10.1161/circep.120.008631
Autor:
Anbukarasi Maran, Ashley Waring, J. Madison Hyer, David D. Daly, Michael R. Gold, J. Lacy Sturdivant, Frank Cuoco, Robert B. Leman, Frederick W. Funke
Publikováno v:
Pacing and Clinical Electrophysiology. 39:863-869
Background Cardiac resynchronization therapy (CRT) improves functional status, reduces heart failure hospitalizations, and decreases mortality. Several comorbidities including renal function affect outcomes with CRT. However, moderate to severe chron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7dcea092bf64fcf5d435925953029aa
https://doi.org/10.1111/pace.12883
https://doi.org/10.1111/pace.12883
Publikováno v:
Heart rhythm. 15(10)
Background Controversy remains regarding the use of cardiac resynchronization therapy (CRT) in patients with heart failure with right bundle branch block (RBBB) and reduced left ventricular (LV) ejection fraction. Moreover, little is known about acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d43090d170d6277777b61e32a2237246
https://pubmed.ncbi.nlm.nih.gov/30817900
https://pubmed.ncbi.nlm.nih.gov/30817900
Publikováno v:
Journal of Cardiovascular Electrophysiology. 25:624-630
Effect of QLV on CRT Hemodynamic Response Introduction Cardiac resynchronization therapy (CRT) improves hemodynamic function, as well as reduces hospitalizations and mortality among patients with systolic dysfunction, QRS prolongation, and heart fail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24be1d2a8aeefb94f34b22aa6d452ebd
https://doi.org/10.1111/jce.12372
https://doi.org/10.1111/jce.12372
Autor:
William W. Brabham, J. Lacy Sturdivant, J. Marcus Wharton, Darren S. Sidney, Michael R. Gold, Christopher P. Rowley, Robert B. Leman, Peter C. Netzler, Michael L. Bernard, Frank Cuoco
Publikováno v:
The American Journal of Cardiology. 111:1165-1168
The perioperative bleeding risk associated with therapeutic anticoagulation at cardiac implantable electronic device implantation has previously been demonstrated to vary by the specific anticoagulant used. Although uninterrupted anticoagulation with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef0dc8841bf1dda7ab5f0483e2cc1da
https://doi.org/10.1016/j.amjcard.2012.12.046
https://doi.org/10.1016/j.amjcard.2012.12.046
Autor:
David D, Daly, Anbukarasi, Maran, J Madison, Hyer, Frederick, Funke, Ashley, Waring, Frank A, Cuoco, J Lacy, Sturdivant, Robert B, Leman, Michael R, Gold
Publikováno v:
Pacing and clinical electrophysiology : PACE. 39(8)
Cardiac resynchronization therapy (CRT) improves functional status, reduces heart failure hospitalizations, and decreases mortality. Several comorbidities including renal function affect outcomes with CRT. However, moderate to severe chronic kidney d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a64a528333ffa7ca203a9ecebf4f4f2
https://pubmed.ncbi.nlm.nih.gov/27197959
https://pubmed.ncbi.nlm.nih.gov/27197959
Autor:
Sonar Pradhan, Michael R. Gold, Steven J. Bailin, Ashish Oza, J. Lacy Sturdivant, John P. Payne, Amir Hedayati, Jamshid Alaeddini
Publikováno v:
Heart Rhythm. 8:1008-1013
Background Defibrillation thresholds (DFTs) are typically stable over time among patients with implantable cardioverter-defibrillators (ICDs). However, the impact of cardiac resynchronization therapy (CRT) on DFTs has not been studied systematically.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1411f0ffa5550a03ccd544bbfe60f641
https://doi.org/10.1016/j.hrthm.2011.02.006
https://doi.org/10.1016/j.hrthm.2011.02.006
Autor:
Matthew S. Forcina, Robert H. Yoe, William H. Spencer, Michael R. Gold, Valerian L. Fernandes, Jason B. Coker, Christopher D. Nielsen, Robert B. Leman, J. Marcus Wharton, J. Lacy Sturdivant, Ernest M. Quin, Frank A. Cuoco
Publikováno v:
Journal of Cardiovascular Electrophysiology. 22:569-572
Defibrillation Thresholds in Hypertrophic Cardiomyopathy. Background: Defibrillation threshold (DFT) testing is performed in part to ensure an adequate safety margin for the termination of spontaneous ventricular arrhythmias. Left ventricular mass is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a15b486c73bfd37a17b59a1f6840458
https://doi.org/10.1111/j.1540-8167.2010.01943.x
https://doi.org/10.1111/j.1540-8167.2010.01943.x
Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract
Autor:
Michael R. Gold, J. Marcus Wharton, Frank Cuoco, Carl R. Reynolds, Robert B. Leman, Vladimir P. Nikolski, J. Lacy Sturdivant
Publikováno v:
Heart Rhythm. 7:1561-1566
Background Implantable cardioverter-defibrillator (ICD) leads are traditionally placed in the right ventricular apex (RVA), in part because this is considered the preferred vector for minimizing defibrillation threshold (DFT). However, if adequate DF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0675c767c9b48bd3f167b96de36c4ecc
https://doi.org/10.1016/j.hrthm.2010.06.017
https://doi.org/10.1016/j.hrthm.2010.06.017
Publikováno v:
Pacing and Clinical Electrophysiology. 32:24-28
Introduction: High defibrillation threshold (DFT) with an inadequate defibrillation safety margin remains an infrequent but troubling problem associated with defibrillator implantation. Dofetilide is a selective class III antiarrhythmic drug that red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99fc5a579e54e659d02638fbddcb9bd
https://doi.org/10.1111/j.1540-8159.2009.02172.x
https://doi.org/10.1111/j.1540-8159.2009.02172.x